In a sweltering Paris 🇫🇷 it’s been a privilege to take part in the European Society of Human Reproduction and Embryology (ESHRE) Congress — the world’s largest gathering of professionals in reproductive medicine and embryology.

So many great conversations, catch-ups and new learnings and connections forged — all united by a shared mission to improve fertility outcomes in the face of mounting global challenges (with eye-opening insights in Merck Healthcare’s symposium about the impact of declining fertility rates and how equitable access to ART is vital). 👶

Grateful for the support and introductions facilitated by our co-lead clinical advisor and British Fertility Society spokesperson, Stuart Lavery, and proud to showcase how our Callavid® drug delivery platform is poised to improve patient experience and outcomes in fertility care.

Already looking forward to next year’s congress — on home turf in London! Preferably not during a heatwave! 🥵